PRESS RELEASE ABBOTT PARK.
PRESS RELEASE ABBOTT PARK, Ill http://viagra-danmark.net .,June 16, 2015/PRNewswire/ –Abbott today verified its continued support for MylanN.V's development strategy by stating its intent to voteits 14.5 % stake inMylan in favor of Mylan's proposed acquisition of Perrigo. ‘We chose Mylanto acquire our created markets top quality generics pharmaceuticals because itsscale and breadth across critical distribution channels,broad anddiverseportfolio, andcommitment to patients and product qualitystronglypositionsitfor achievement in the years to come,’ saidMiles D. White colored, chairman and chief executive officer, Abbott. ‘As bothMylan's largestshareholder and itspartner through our continued manufacturing relationships,Abbott offers considered the entire circumstance and we believe Mylan's standalone technique and acquisition of Perrigo can further enhanceits platform, is strategically compelling, worth enhancing for shareholders, and offers a clear way to completion.
THE UNITED STATES revenues of $41.8 million, up 31 percent over last year's comparable quarter. Medical marketplace revenues of $9.0 million, up 10 percent over last year's comparable quarter. Veterinary market revenues of $39.9 million, up 40 percent over last year's comparable quarter. Total medical and veterinary instrument revenues of $14.0 million, up 54 percent over last year's comparable quarter. Total medical and veterinary instrument sales of just one 1,818 units, up 52 percent over last year's comparable quarter.